Axonal's Agentic AI Collaborative Workspace leverages multi-agent technology to shorten the time from insights to actions and ...

This important paper takes a novel approach to the problem of automatically reconstructing long-range axonal projections from stacks of images. The key innovation is to separate the identification of ...

The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...

Curis, Inc. ("Curis") , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and ...

Karl Fitzpatrick has described his frightening ordeal after being diagnosed with potentially life-threatening Guillain–Barré ...

today announced that Michael Ehlers, M.D., Ph.D., will join the Company as Entrepreneur Partner.... Axonal.AI today unveiled its groundbreaking platform, designed to significantly accelerate speed to ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...

The investigators added that inflammation and demyelination were reduced, while axonal density oligodendrocytes, ...

The plea says the petitioner's family has done its best to treat him. However, he has been confined to bed by a diffuse ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and... corporate communications solutions . With broad reach and a seasoned team of ...

It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 ...